Who is sponsoring PIANO?

PIANO is sponsored by Light Chain Bioscience - Novimmune SA.

What condition does PIANO study?

PIANO studies Primary Biliary Cirrhosis.

Last reviewed 2014-04-03 · How we verify

An Open Label Single Arm Study to Investigate the Safety and Efficacy of Multiple Administrations of NI-0801, a Fully Human Anti-CXCL10 Monoclonal Antibody in PBC Patients With an Incomplete Response to Ursodeoxycholic Acid (PIANO)

NCT01430429 Phase 2 TERMINATED

The purpose of the study is to assess safety and efficacy of multiple doses of NI-0801 in primary biliary cirrhosis patients with an inadequate response to ursodeoxycholic acid.

Details

Lead sponsor	Light Chain Bioscience - Novimmune SA
Phase	Phase 2
Status	TERMINATED

Conditions

Primary Biliary Cirrhosis

Interventions

NI-0801

Countries

Italy, United Kingdom